Across TCGA pan-cancer cohorts, RNU1-133P Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated RNU1-133P data layer compared with 9 for mass-spec protein.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher RNU1-133P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RNU1-133P expression acts as an unfavorable survival marker.

CHOL are the cancer types where RNU1-133P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Median	All	0.155	0.725	.029	3	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: RNU1-133P tumor-vs-normal RNA expression · all RNU1-133P data types